Research Analysts Set Expectations for MMSI FY2025 Earnings

Merit Medical Systems, Inc. (NASDAQ:MMSI) – Equities research analysts at Zacks Research dropped their FY2025 earnings estimates for Merit Medical Systems in a report issued on Tuesday, March 18th. Zacks Research analyst I. Bandyopadhyay now anticipates that the medical instruments supplier will earn $3.67 per share for the year, down from their prior estimate of $3.70. The consensus estimate for Merit Medical Systems’ current full-year earnings is $3.37 per share.

A number of other equities analysts have also weighed in on MMSI. Piper Sandler reiterated an “overweight” rating and issued a $116.00 price target (up from $114.00) on shares of Merit Medical Systems in a research report on Wednesday, January 29th. Needham & Company LLC dropped their price target on shares of Merit Medical Systems from $122.00 to $116.00 and set a “buy” rating for the company in a research report on Wednesday, February 26th. Canaccord Genuity Group dropped their price target on shares of Merit Medical Systems from $128.00 to $127.00 and set a “buy” rating for the company in a research report on Wednesday, February 26th. Wells Fargo & Company dropped their price target on shares of Merit Medical Systems from $120.00 to $117.00 and set an “overweight” rating for the company in a research report on Wednesday, February 26th. Finally, Barrington Research dropped their target price on shares of Merit Medical Systems from $115.00 to $111.00 and set an “outperform” rating for the company in a research report on Wednesday, February 26th. Two investment analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, Merit Medical Systems presently has an average rating of “Moderate Buy” and a consensus target price of $110.78.

Merit Medical Systems Stock Performance

MMSI opened at $101.28 on Friday. The firm has a market cap of $5.96 billion, a P/E ratio of 49.65, a PEG ratio of 2.34 and a beta of 0.91. Merit Medical Systems has a 1-year low of $70.70 and a 1-year high of $111.45. The company has a 50 day simple moving average of $103.82 and a two-hundred day simple moving average of $100.71. The company has a debt-to-equity ratio of 0.57, a current ratio of 5.36 and a quick ratio of 3.82.

Insider Buying and Selling at Merit Medical Systems

In other Merit Medical Systems news, CFO Raul Jr. Parra sold 12,451 shares of the stock in a transaction on Friday, February 28th. The shares were sold at an average price of $98.81, for a total transaction of $1,230,283.31. Following the completion of the transaction, the chief financial officer now owns 24,201 shares in the company, valued at $2,391,300.81. This trade represents a 33.97 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Brian G. Lloyd sold 25,000 shares of the stock in a transaction on Friday, February 28th. The shares were sold at an average price of $99.50, for a total transaction of $2,487,500.00. Following the transaction, the insider now owns 38,993 shares of the company’s stock, valued at $3,879,803.50. This trade represents a 39.07 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 109,132 shares of company stock worth $11,139,521 over the last 90 days. 3.70% of the stock is owned by insiders.

Institutional Investors Weigh In On Merit Medical Systems

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Peak Retirement Planning Inc. purchased a new stake in shares of Merit Medical Systems in the fourth quarter valued at $875,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of Merit Medical Systems by 17.4% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 165,344 shares of the medical instruments supplier’s stock valued at $15,992,000 after acquiring an additional 24,528 shares during the period. iSAM Funds UK Ltd purchased a new stake in shares of Merit Medical Systems in the fourth quarter valued at $424,000. Virtus Investment Advisers Inc. raised its stake in shares of Merit Medical Systems by 45.7% in the fourth quarter. Virtus Investment Advisers Inc. now owns 11,192 shares of the medical instruments supplier’s stock valued at $1,082,000 after acquiring an additional 3,513 shares during the period. Finally, Tidal Investments LLC raised its stake in shares of Merit Medical Systems by 3,197.9% in the fourth quarter. Tidal Investments LLC now owns 342,912 shares of the medical instruments supplier’s stock valued at $33,166,000 after acquiring an additional 332,514 shares during the period. Hedge funds and other institutional investors own 99.66% of the company’s stock.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.